BE Pharmaceuticals Revenue and Competitors

BE Pharmaceuticals is a privately held generic sterile injectable company which was established in 2019 as a regional expansion of Biological E. Limited (BioE). BE Pharmaceuticals entered the US Market with the goal of providing quality medications at an affordable price. This is backed by the success and reputation of BioE in the international market as the first private sector biological products company in India, and the first private sector company to enter the vaccine business in India. BioE is one of the leading vaccine companies in India and partners with global healthcare agencies, including the WHO, UNICEF and Pan American Health Organization in their efforts to make life saving vaccines accessible globally. BioE supplies its vaccines to more than 100 countries and has supplied more than 2 billion doses of vaccines in the last decade alone. With modern manufacturing facilities that are well equipped for sterile manufacturing of quality products, BE Pharmaceuticals is well positioned to make an impact in our communities by supplying quality generic sterile injectables to the US market at an affordable price.